Advertisement

Author: Staff

John Viscogliosi is the chairman and CEO of Centinel Spine. He is also a founding member and principal of Viscogliosi Brothers, a private equity firm focused on the orthopedic industry.

Advertisement

In 2018, Kuros Biosciences recorded the first sales of its MagnetOs bone graft substitute in the U.S. and Europe and raised capital to fund a phase 2 clinical trial of its spinal fusion product.

Advertisement